iSTEP - an mHealth Physical Activity and Diet Intervention for Persons With HIV
2 other identifiers
interventional
100
1 country
1
Brief Summary
HIV is associated with a pattern of neurocognitive deficits, metabolic dysfunction, and an elevated risk for cardiovascular disease (CVD), phenomena that remain untreated despite the use of medications to control the disease. This proposal will examine the effect of a personalized, automated, interactive mobile phone text message intervention (iSTEP) designed to increase moderate physical activity (PA), decrease sedentary behavior (SB), and promote a healthy Mediterranean-style diet (MedDiet) in persons living with HIV (PLWH). The investigators propose that participants who receive the iSTEP intervention will increase the amount of physical activity, improve their diet, show a reduction in risk factors for CVD, and exhibit improved neurocognitive performance.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Dec 2018
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 11, 2017
CompletedFirst Posted
Study publicly available on registry
April 21, 2017
CompletedStudy Start
First participant enrolled
December 1, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 15, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
August 15, 2023
CompletedResults Posted
Study results publicly available
September 19, 2024
CompletedSeptember 19, 2024
August 1, 2024
4.7 years
April 11, 2017
July 15, 2024
August 26, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Physical Activity - Total Steps Recorded During 24 Weeks
Total number of steps recorded by the Fitbit over 24 weeks. Zero is the minimum and there is no maximum. Higher scores (steps) indicates a better outcome.
6 months
Secondary Outcomes (10)
Physical Activity - Change in Average Daily Steps Per Day Between Week 1 and Week 24
24 weeks
Average Steps Per Day During the 24-week Intervention
24 weeks
C-reactive Protein
24 weeks
Change in Total Cholesterol.
24 weeks
Level of GPLD1 (Phosphatidylinositol-glycan-specific Phospholipase D) Enzyme at the Baseline Visit
1 day baseline visit
- +5 more secondary outcomes
Study Arms (3)
Control Arm
ACTIVE COMPARATORParticipants will wear a Fitbit but will not receive any additional elements of the iSTEP intervention.
iSTEP PA intervention
EXPERIMENTALParticipants will wear a Fitbit and receive interactive daily text messages that are designed to motivate moderate physical activity (PA) and reduce sedentary behavior, including setting weekly goals to increase average daily step counts.
iSTEP PA and diet intervention
EXPERIMENTALParticipants will wear a Fitbit and receive interactive daily text messages that are designed to motivate moderate physical activity (PA), reduce sedentary behavior, and promote adherence to a Mediterranean-style diet. Participants will also be administered diet counseling from a registered dietitian and receive weekly feedback on both physical activity and diet behaviors.
Interventions
Eligibility Criteria
You may qualify if:
- ability to provide informed consent
- HIV infection documented at the University of California, San Diego (UCSD) HIV Neurobehavioral Research Program (HNRP) or assessed by an HIV test at screening
- proficient in English
- physically capable of participating in moderate PA as screened by the Physical Activity Readiness Questionnaire
- consent from primary care physician to participate in the study
- able to consume walnuts - no nut allergies
You may not qualify if:
- any physical conditions that would prevent moderate physical activity or where moderate physical activity would represent a health risk for the individual, including a history of myocardial infarction or stroke
- unwillingness or inability to participate in daily text messaging
- tree nut allergy that would prevent walnut consumption or other food restrictions that would prevent participation in the Mediterranean-style diet intervention (e.g., unable to eat fish or use olive oil for cooking).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
HIV Neurobehavioral Research Program
San Diego, California, 92103, United States
Related Publications (1)
Henry BL, Quintana E, Moore DJ, Garcia J, Montoya JL. Focus groups inform a mobile health intervention to promote adherence to a Mediterranean diet and engagement in physical activity among people living with HIV. BMC Public Health. 2019 Jan 22;19(1):101. doi: 10.1186/s12889-018-6386-5.
PMID: 30669986DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Dr. Brook Henry
- Organization
- University of California, San Diego
Study Officials
- PRINCIPAL INVESTIGATOR
Brook L Henry, Ph.D.
University of California, San Diego
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Project Scientist
Study Record Dates
First Submitted
April 11, 2017
First Posted
April 21, 2017
Study Start
December 1, 2018
Primary Completion
August 15, 2023
Study Completion
August 15, 2023
Last Updated
September 19, 2024
Results First Posted
September 19, 2024
Record last verified: 2024-08
Data Sharing
- IPD Sharing
- Will not share